|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/428 | |||
| A61K 9/20 | |||
| A61K 9/08 | |||
| A61K 47/20 | |||
| A61K 47/26 | |||
| A61P 25/00 | |||
| A61P 25/16 | |||
| A61P 25/18 | |||
| A61P 25/22 | |||
| A61P 25/24 | |||
| A61P 25/28 | |||
| A61P 25/30 |
| (11) | Number of the document | 3616686 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19186196.2 |
| Date of filing the European patent application | 2015-11-17 | |
| (97) | Date of publication of the European application | 2020-03-04 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-19 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201462083094 P | 2014-11-21 | US |
| (72) |
CORIC, Vladimir, US
BERMAN, Robert, M., US
VLADYKA, Ronald, Samuel, US
SALEH, Amgad, US
YU, Danny, US
|
| (73) |
Biohaven Pharmaceutical Holding Company Ltd.,
234 Church Street Suite 301, New Haven, CT 06520,
US
|
| (54) | SUBLINGUAL FORMULATION OF RILUZOLE |
| SUBLINGUAL FORMULATION OF RILUZOLE |